APA (7th ed.) Citation

Hengeveld, M., Suciu, S., Chelgoum, Y., Marie, J., Muus, P., Lefrère, F., . . . de Witte, T. (2015). High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT. Bone Marrow Transplantation, 50(3), 341. https://doi.org/10.1038/bmt.2014.262

Chicago Style (17th ed.) Citation

Hengeveld, M., et al. "High Numbers of Mobilized CD34+ Cells Collected in AML in First Remission Are Associated with High Relapse Risk Irrespective of Treatment with Autologous Peripheral Blood SCT or Autologous BMT." Bone Marrow Transplantation 50, no. 3 (2015): 341. https://doi.org/10.1038/bmt.2014.262.

MLA (9th ed.) Citation

Hengeveld, M., et al. "High Numbers of Mobilized CD34+ Cells Collected in AML in First Remission Are Associated with High Relapse Risk Irrespective of Treatment with Autologous Peripheral Blood SCT or Autologous BMT." Bone Marrow Transplantation, vol. 50, no. 3, 2015, p. 341, https://doi.org/10.1038/bmt.2014.262.